March 2020

Tests show that taking the drug for six months may increase the remission in men 2 and 3 years after surgery. More details of the test are here:

https://www.targetedonc.com/news/enzalutamide-plus-standard-treatment-may-extend-remission-in-highrisk-recurrent-prostate-cancer